CODICE |
DESCRIZIONE |
CAS-N |
CONFEZIONE |
|
|
224190050 |
(S)-(+)-2-Methylbutyric acid, 98% |
1730-91-2 |
5GR |
|
|
224190250 |
(S)-(+)-2-Methylbutyric acid, 98% |
1730-91-2 |
25GR |
|
|
356260050 |
(S)-(+)-2-Methylpiperazine, 98% |
74879-18-8 |
5GR |
|
|
439330010 |
(S)-(+)-2-Oxo-4-phenyl-3-oxazolidineacetic acid, 98% |
99333-54-7 |
1GR |
|
|
439330010 |
(S)-(+)-2-Oxo-4-phenyl-3-oxazolidineacetic acid, 98% |
99333-54-7 |
1GR |
|
|
442190100 |
(S)-(+)-2-Phenylglycine methyl ester hydrochloride, 97% |
15028-39-4 |
10GR |
|
|
442190500 |
(S)-(+)-2-Phenylglycine methyl ester hydrochloride, 97% |
15028-39-4 |
50GR |
|
|
307570010 |
(S)-(+)-2-Phenylglycinol, 98% |
20989-17-7 |
1GR |
|
|
307570050 |
(S)-(+)-2-Phenylglycinol, 98% |
20989-17-7 |
5GR |
|
|
307570250 |
(S)-(+)-2-Phenylglycinol, 98% |
20989-17-7 |
25GR |
|
|
264650010 |
(S)-(+)-2-Phenylpropionic acid, 99% |
7782-24-3 |
1GR |
|
|
264652500 |
(S)-(+)-2-Phenylpropionic acid, 99% |
7782-24-3 |
250MG |
|
|
437490010 |
(S)-(+)-3-Amino-1-BOC-piperidine, 95% |
625471-18- |
1GR |
|
|
437490050 |
(S)-(+)-3-Amino-1-BOC-piperidine, 95% |
625471-18- |
5GR |
|
|
304430010 |
(S)-(+)-3-Hydroxytetrahydrofuran, 99% |
86087-23-2 |
1GR |
|
|
304430050 |
(S)-(+)-3-Hydroxytetrahydrofuran, 99% |
86087-23-2 |
5GR |
|
|
304430250 |
(S)-(+)-3-Hydroxytetrahydrofuran, 99% |
86087-23-2 |
25GR |
|
|
304430010 |
(S)-(+)-3-Hydroxytetrahydrofuran, 99% |
86087-23-2 |
1GR |
|
|
304430050 |
(S)-(+)-3-Hydroxytetrahydrofuran, 99% |
86087-23-2 |
5GR |
|
|
304430250 |
(S)-(+)-3-Hydroxytetrahydrofuran, 99% |
86087-23-2 |
25GR |
|
|
436520010 |
(S)-(+)-3-Piperidinamine dihydrochloride, 97% |
334618-07- |
1GR |
|
|
436520050 |
(S)-(+)-3-Piperidinamine dihydrochloride, 97% |
334618-07- |
5GR |
|
|
389230010 |
(S)-(+)-4-Methyl-2-pentanol, 99%, (99+% ee) |
14898-80-7 |
1GR |
|
|
303850010 |
(S)-(+)-4-Phenyl-2-oxazolidinone, 99% |
99395-88-7 |
1GR |
|
|
303850050 |
(S)-(+)-4-Phenyl-2-oxazolidinone, 99% |
99395-88-7 |
5GR |
|
|
303850010 |
(S)-(+)-4-Phenyl-2-oxazolidinone, 99% |
99395-88-7 |
1GR |
|
|
303850050 |
(S)-(+)-4-Phenyl-2-oxazolidinone, 99% |
99395-88-7 |
5GR |
|
|
348410010 |
(S)-(+)-5-(Hydroxymethyl)-2-pyrrolidinone p-toluenesulfonate, 95% |
51693-17-5 |
1GR |
|
|
348410050 |
(S)-(+)-5-(Hydroxymethyl)-2-pyrrolidinone p-toluenesulfonate, 95% |
51693-17-5 |
5GR |
|
|
348410250 |
(S)-(+)-5-(Hydroxymethyl)-2-pyrrolidinone p-toluenesulfonate, 95% |
51693-17-5 |
25GR |
|
|
303140010 |
(S)-(+)-5-Hydroxymethyl-2-pyrrolidinone, 97% |
17342-08-4 |
1GR |
|
|
303140050 |
(S)-(+)-5-Hydroxymethyl-2-pyrrolidinone, 97% |
17342-08-4 |
5GR |
|
|
428180010 |
(S)-(+)-alpha-(Trifluoromethyl)benzyl alcohol, 99% |
340-06-7 |
1GR |
|
|
264110010 |
(S)-(+)-alpha-Methoxy-alpha-(trifluoromethyl)phenylacetyl chloride, 99% |
20445-33-4 |
1GR |
|
|
264112500 |
(S)-(+)-alpha-Methoxy-alpha-(trifluoromethyl)phenylacetyl chloride, 99% |
20445-33-4 |
250MG |
|
|
224490010 |
(S)-(+)-alpha-Methoxyphenylacetic acid, 99% |
26164-26-1 |
1GR |
|
|
224490050 |
(S)-(+)-alpha-Methoxyphenylacetic acid, 99% |
26164-26-1 |
5GR |
|
|
349020010 |
(S)-(+)-Epichlorohydrin, 98% |
67843-74-7 |
1GR |
|
|
337640010 |
(S)-(+)-gamma-Hydroxymethyl-gamma-butyrolactone, 97% |
32780-06-6 |
1GR |
|
|
337640050 |
(S)-(+)-gamma-Hydroxymethyl-gamma-butyrolactone, 97% |
32780-06-6 |
5GR |
|
|
337642500 |
(S)-(+)-gamma-Hydroxymethyl-gamma-butyrolactone, 97% |
32780-06-6 |
250MG |
|
|
296420025 |
(S)-(+)-Glycidyl nosylate, 98% |
115314-14- |
2.5GR |
|
|
296420100 |
(S)-(+)-Glycidyl nosylate, 98% |
115314-14- |
10GR |
|
|
296420500 |
(S)-(+)-Glycidyl nosylate, 98% |
115314-14- |
50GR |
|
|
333200010 |
(S)-(+)-Ibuprofen, 99% |
51146-56-6 |
1GR |
|
|
333200050 |
(S)-(+)-Ibuprofen, 99% |
51146-56-6 |
5GR |
|
|
125300250 |
(S)-(+)-Mandelic acid, 99+% |
17199-29-0 |
25GR |
|
|
125301000 |
(S)-(+)-Mandelic acid, 99+% |
17199-29-0 |
100GR |
|
|
397580010 |
(S)-(+)-N-BOC-3-pyrrolidinol, 98+% |
101469-92- |
1GR |
|
|
397580050 |
(S)-(+)-N-BOC-3-pyrrolidinol, 98+% |
101469-92- |
5GR |
|
|